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ABSTRACT 
Objectives: There are many variations in prescribing patterns of Diabetes mellitus with hypertension which requires lifelong treatment as 
enormously increased the burden of chronic diseases and needs much care while choosing drugs. In a tertiary care Centre, prescribing pattern are 
powerful tools to ascertain the role of drugs in society. Hence, there is a need for appropriate, safe, effective and economical study to find out the 
patterns of drug therapy among diabetic hypertensive patients with other complications.  
Methods: Retrospective, randomized and non-interventional study design was conducted from September 2014 to November 2014 at a Community 
Clinic in Telangana State. The collected data are thoroughly analyzed and prescriptions were checked for appropriateness. For easy sorting all data 
obtained were entered into Microsoft Excel 2000 and cross-checked for accuracy. The data collected were analyzed to obtain averages, percentages 
and standard deviations. The data were grouped on the bases of age, gender, fasting blood glucose, blood pressure, co morbidities, various classes of 
drugs and analyzed for significance. 
Results: A total of 109 patients were included in this two months study. All the patients had Type 2 diabetes, while 18 patients also had 
Hypertension (on treatment). All the patients were on treatment for Type 2 Diabetes. The mean fasting Blood sugar was 119.27±40.34 mg/dl, while 
the mean post-prandial blood sugar was 212.78±67.35 mg/dl. The average number of OHAs per prescription was 1.99±0.54. About 19.26% of the 
patients were on monotherapy with Metformin, while all the other patients received a combination of oral hypoglycemic agents. Insulin was used in 
2.75% of the patients. Among combinations, the most commonly used combination was glibenclamide and metformin 41.2%. 
Conclusion: Metformin is the drug of choice and glibenclamide is the most preferred combination with Metformin. Insulin was not preferred as 
monotherapy. Despite combination therapy, the post-prandial glucose levels were not in range–suggesting either poor patient compliance or 
inadequate dosing/inappropriate therapy. In addition to drugs, the services of a clinical pharmacist might be helpful in these patients.  
Keywords: Prescription Pattern, Diabetes Mellitus, Oral Hypoglycemic Agents, Community. 
 
INTRODUCTION 
Diabetes mellitus (DM) is a pandemic disease that has struck each 
and every corner of the world. According to the Indian council of 
medical research-Indian diabetes study (ICMR), a national 
diabetes study currently has 62.4 million people with diabetes [1]. 
This is set to increase to over 100 million by 2030 [2]. The 
prevalence of diabetes among adults has reached approximately 
20% in urban and approximately 10% in the rural population in 
India [3]. Indian onset of diabetes is about a decade earlier than 
their western counterparts [4]. 
Diabetes treatment depends on the type and severity of the diabetes. 
The two types of diabetes are referred to as type 1 (insulin 
dependent) and type 2 (non-insulin dependent). Insulin is vital to 
patients with type 1 diabetes they cannot live without a source of 
exogenous insulin. Type 2 diabetes is first treated with weight 
reduction, a diabetic diet and exercise when these measures fail to 
control the elevated blood sugars and oral medications are used. If 
oral medications are still insufficient, insulin medications are 
considered [5]. Various classes of anti-diabetic drugs including 
insulin and oral hypoglycemic agents (OHA) are currently used in 
the treatment of diabetes, which acts by different mechanisms to 
reduce the blood-glucose levels to maintain optimal glycemic control 
[6, 7]. Hypertension (HT) is frequently associated with diabetes 
mellitus (DM) and its prevalence doubles in diabetics compared to 
the general population. This high prevalence is associated with 
increased stiffness of large arteries, which often precedes macro 
vascular events [8]. The rapidly growing number of patients with 
coexisting diabetes and hypertension must be intensively treated to 
protect them from their very high risk for premature cardiovascular 
morbidity and mortality [9]. 
Negative attitude of patients towards diabetes managements such as 
dietary modifications, exercise, and insulin therapy are common and 
ultimately can lead to diabetic complications [10]. About 18% of 
patients perceive that balanced diet low in sugar/sweets is 
important for diabetes control while 52% thought that only sweets 
should be stopped [11]. Negative attitude can be developed due to 
various reasons one of which is lack of education [12]. Thus better 
understanding of perceptions and attitudes among both patients and 
providers is needed to guide initiatives to improve the management 
of diabetes [13, 14]. Though diabetes is the fatal disease of our 
knowledge, there are no comprehensive studies conducted in the 
study area. 
Thus, this study is aimed to find out the trends of prescribing anti-
diabetics in community aclinic in Telangana State and what factors 
determine the prescribing of a particular anti-diabetic drug or a 
combination of multiple drugs, prevalence of diabetes related 
complications and related risk factors, identifying the prescribing 
errors and treatment adherence as per the JNC VII guidelines with 
its related barriers. 
MATERIALS AND METHODS 
The intended work can be divided into the following steps.  
Step 1: To collect randomly the prescriptions of patients diagnosed 
with diabetes.  
Step 2: To separate the prescriptions prescribing Anti Diabetic 
Drugs and the ones without anti diabetic drugs.  
Step 3: To divide the prescriptions into various groups according to 
the following: Age and sex of patient and diseases associated with 
DM.  
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Step 4: To statistically analyze the prescriptions on the following 
aspects:  
• Demographic characters of patients. 
• Showing incidence of DM according to sex.  
• Showing incidence of DM according to different age groups.  
• Analysis of Prescription in DM with respect to dosage forms.  
• Analysis of prescription showing incidence with other diseases.  
• Patterns of utilization of major Pharmacological drug classes.  
Step 5: To analyse the frequency of diseases associated with DM 
statistically and the drugs according to their pharmacological 
categories.  
Location 
The study was conducted in the Community Clinic, Warangal Dist, 
Telangana State. 
Study design 
It was a retrospective randomized non interventional study. 
Study period 
Data were collected from September 2014 to November 2014 in 
between 9 am to 12pm in the Community clinic. 
Inclusion criteria 
• Patients suffering from type2 diabetes mellitus attending the 
community clinic 
• Diabetic patients of either sex. 
• Diabetic patients above 18years. 
• Diabetic patients having co-morbidity of hypertension are only 
included. 
Exclusion criteria 
• Pregnant females suffering from diabetes. 
• Diabetic patients suffering from complications of diabetes like 
retinopathy, neuropathy and diabetic foot. 
Patient consent 
The patient and their bystanders were briefed about the study and 
consent was obtained prior to their enrolment through the consent 
form as shown in annexure I. 
Data collection  
A data collection format was designed to aid the collection of data as 
shown in annexure II.  
Case notes  
Data on sex, age, groups of medicines prescribed, number of 
prescriptions and number of medicines occurring per prescription 
were obtained. 
Data analysis  
The collected data were thoroughly analyzed and prescriptions were 
checked for appropriateness. For easy sorting all data obtained were 
entered into Microsoft Excel 2007 and cross-checked for accuracy. 
The data collected were analyzed to obtain averages, percentages 
and standard deviations.  
Ethical issues  
Permission was sought and obtained from the Clinic Physician Dr. 
Batchu Murali Krishna M. D., D. Diab, before commencement of study. 
RESULTS 
A total of 109 patients were included in this one month study. All the 
patients had type 2 diabetes, while 18 patients also had Hyper 
tension (on treatment). All the patients were on treatment for type 2 
diabetes. The mean fasting Blood sugar was 119.27±40.34 mg/dl, 
while the mean post-prandial blood sugar was 212.78±67.35 mg/dl. 
The average number of OHA per prescription was 1.99±0.54.  
 
Table 1: Age and sex distribution of diabetic patients 
Age in years Male Female Total 
30-40 10 15 25 
41-50 10 12 22 
51-60 19 31 50 
61-70above 5 7 12 
Total (%) 40.36% 59.64% 100% 
 
Table 2: Percentage of drugs prescribed 
Name of drug Dosage form No. of times prescribed % Of total no of Anti-diabetic drug prescribed 
metformin tablet(250 mg,500 mg) 22 20.18% 
voglibose tablet(0.2 mg,0.3 mg) 4 3.66% 
human insulin injection(16IU) 2 1.83% 
isophane insulin injection(16IU) 1 0.91% 
glibenclamide+metformin tablet(2.5 mg+500 mg,5 mg+500 mg) 45 41.2% 
glimepiride+metformin tablet(1 gm+500 mg,2 gm+500 mg) 42 38.53% 
 
Out of 109 patients, most of the patients 50 were in the age group of 
51-60 years while, 25 were in the age group of 30-40 years, followed 
by 22 were in age group of 41-50 years and 12 were in age group of 
61-70 years. These demographic characteristics related to age and 
gender were shown in the table 1. 
A total of 6 drugs were used during the time of study, in which 
glibenclamide+metformin was the most preferred drug combination 
followed byglimepiride+metformin. The former was used in 
45(41.2%) prescriptions while latter was used in 42(38.53%) of 
them. The less commonly used anti-diabetic drugs were human 
insulin and isophane insulin.  
They were used in only 2(1.83%) and 1(0.91%) prescriptions. The 
percentages of drugs prescribed were shown in table 2 and 
Percent of the total number of anti-diabetic drug prescribed is 
shown in fig. 1. 
 
Fig. 1: Percentage of drugs prescribed
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Table 3: Description of drugs present in each prescription 




No. of prescription containing 
oral diabetic drug  
No. of prescription 
with Insulin  
No. of prescription containing anti-hypertensive 
agents along with Anti-diabetic drugs 
1 21 21 - 2 
2 76 75 1 14 
3 11 10 1 2 
4 1 - 1 - 
Total 109 106 3 18 
 
In this study, a total of 6 anti-diabetic drugs were used for the 
treatment of diabetes and 5 anti-hypertensive agents were used 
for hypertension along with anti-diabetic drugs. 21 prescriptions 
received a single drug, while 76 prescriptions received 
combination of two drugs. 11 prescriptions received a 
combination of three drugs and only 1 prescription received four 
drugs at a time. The description of drugs present in each 
prescription shown in table 3. 
 
Table 4: Analysis of anti-hypertensive drug combinations 
Drugs Number of prescription Frequency 
Prazocin 2 OD 
Spironolactone 1 OD 
Telmisartan 6 OD 
Telmisartan+Hydrochlorothiazide 7 OD 
Torsemide+Spironolactone 2 OD 
 
A Total of 5 anti-hypertensive agents were used in 18 prescriptions 
of hypertension patients along with anti-diabetic drugs. In which 
Telmisartan+Hydrochlorothiazide was most preferred one followed 
by Telmisartan, Torsemide+Spironolactone, Prazocin and less 
common was Spironolactone. The analysis of anti-hypertensive drug 
combinations was shown table 4. 
 
 
Fig. 2: Distribution of Insulin and OHA 
 
In the study period, Insulin and Oral Hypoglycemic Agents (OHA) 
were used. A majority of 97.24% prescriptions received OHA while 
only 2.75% prescriptions received Insulin. The distribution of 
Insulin and OHA was shown in fig. 2.  
 
 
Fig. 3: Distribution of therapies 
Out of 109 patients, 80.74%, patients received combination therapy 
and 19.26%, patients received monotherapy as shown in fig. 3. 
DISCUSSION 
In this study, an attempt has been made to describe the current 
prescribing pattern and trend of anti-diabetic drug therapy along 
with the efficacy of these drugs in maintaining an optimal glycemic 
level in diabetic patients in a community clinic in Telangana. 
A total of 108 patients were included in this two months study. All 
the patients had diabetes, while 18 patients also had Hypertension 
(on treatment). All the patients were on treatment for Diabetes. The 
mean fasting Blood sugar was 119.27±40.34 mg/dl, while the mean 
post-prandial blood sugar was 212.78±67.35 mg/dl.  
The average number of OHAs per prescription was 1.99±0.54. 
OHAs were commonly prescribed drugs accounting for 97.24% of 
the total prescribed anti‑ diabetic products. Sulfonylureas plus 
biguanides (77.93%) were the most commonly prescribed class, 
which was similar to previous studies [15, 16], followed by 
biguanides (16.10%). This reflects that sulfonylureas and 
biguanides are still the choice of most physicians in the treatment 
of Diabetes mellitus. 
In spite of sulfonylurea being the commonest class, we observed that 
metformin (biguanide) was the most common individual OHA to be 
prescribed 16.10% which is similar to severalStudies [17, 18]. This 
may be due to the fact that metformin was the only drug of its class 
to be prescribed, whereas many second generation 
The following combinations were the most frequently prescribed: 
Metformin+Glibenclamide (39.8%), Metformin+Glimepiride 
(38.13%). A similar study, as ours conducted by KA Al Khaja, RP 
Sequeira, and VS Mathur concluded that as combinations, 
sulfonylureas plus Metformin was most popular [19]. 
Several studies showed that a combination of sulphonyl urea 
with metformin has been most widely used [20]. The present 
study also showed that a combination of sulphonyl urea and 
metformin was most frequently prescribed (77.93%). Metformin 
does not promote weight gain and has beneficial effects on 
several cardiovascular risk factors. Accordingly, metformin is 
reported to be regarded as the first drug of choice for most 
patients with Diabetes [21]. Our study also supported the same 
conclusion. At present, glibenclamide and glimepiride are the 
second-generation sulphonyl ureas most widely used in the 
United States [22]. 
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Table 5: Drugs prescribed on fasting blood sugar 
Fasting blood sugar Drugs Number of prescription Total number of prescription 









111 mg/dl-130 mg/dl Metformin 2 18 
Glibenclamide+Metformin 8 
Glimipiride+Metformin 8 




151 mg/dl-176 mg/dl Glibenclamide+Metformin 7 8 
Glimipiride+Metformin 1 
180 mg/dl-200 mg/dl Glimipiride+Metformin 3 4 
Glimipiride+Metformin+Voglibose 1 




In this study prescribing pattern was analyzed on the bases of Fasting blood sugar of patients attending the Community Clinic. 
 
CONCLUSION 
The Retrospective, randomized and non-interventional study of 
prescribing pattern of Anti diabetic drug shows Metformin is the 
drug of choice and Glimipiride is the most preferred combination 
with Metformin. Insulin was not preferred as monotherapy. The 
combinations of anti diabetics are prescribed more to achieve a 
better glycemic control in order to avoid longer term complication. 
Despite combination therapy, the post-prandial glucose levels were 
not in range–suggesting either poor patient compliance or 
inadequate dosing/inappropriate therapy. In addition to drugs, the 
services of a clinical pharmacist might be helpful in these patients.  
Limitation 
Being a non-interventional study, data was collected at the given 
time. So no record of subsequent treatment was noted. For 
optimizing drug therapy in diabetic patients it has to be correlated 
with HbA1c level. In present study record of HbA1c level was not 
found in prescription. To achieve therapeutic goal, compliance of 
patients about pharmacological and non-pharmacological treatment 
is necessary. Diabetes mellitus is a chronic condition and demands 
active participation by the patients in adherence to treatment, 
questionnaire based interview regarding awareness, the services of 
a clinical pharmacist might be helpful in these patients. 
  
Abbreviation 
DM Diabetes Mellitus 
ICMR Indian council of medical research 
HT hypertension 
JNC Joint National committee  
OHA oral hypoglycemic agents 
% percentage 
No. Number 
HbA1c Hemoglobin A1c 
OD Once a Day 
mg milligrams 
dl Deciliter 
FBS Fasting blood sugar 
IU International Units 
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